UCLA's Jonsson Comprehensive Cancer Center : JCCC Member Directory

Yong Kim, Ph.D.

Affiliation(s):

Associate Professor, Department of Oral Biology and Medicine

Member, JCCC Cancer and Stem Cell Biology Program Area

Contact Information:

Phone:	(310) 825-7210
Email:	thadyk@ucla.edu

Scientific Interest(s):

Dr. Yong Kim's research is focused on cell cycle regulation and epigenetic regulation in cancer cells and in stem cell maintenance/differentiation.

Selected Cancer-Related Publications:

Peng H, Shintani S, Kim Y, Wong DT. Loss of p12CDK2-AP1 expression in human oral squamous cell carcinoma with disrupted transforming growth factor-beta-Smad signaling pathway. Neoplasia. 2006 Dec;8(12):1028-36.

Kim Y, Ohyama H, Patel V, Figueiredo M, Wong DT. Mutation of Cys105 inhibits dimerization of p12CDK2-AP1 and its growth suppressor effect. J Biol Chem. 2005 Jun 17;280(24):23273-9. Epub 2005 Apr 19.

Figueiredo ML, Kim Y, St John MA, Wong DT. p12CDK2-AP1 gene therapy strategy inhibits tumor growth in an in vivo mouse model of head and neck cancer. Clin Cancer Res. 2005 May 15;11(10):3939-48.

Kim Y, McBride J, Zhang R, Zhou X, Wong DT. p12(CDK2-AP1) mediates DNA damage responses induced by cisplatin. Oncogene. 2005 Jan 13;24(3):407-18.

Kim Y, Shintani S, Kohno Y, Zhang R, Wong DT. Cyclin G2 dysregulation in human oral cancer. Cancer Res. 2004 Dec 15;64(24):8980-6.